The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Rejoice, fellow vaccine enthusiasts-it looks like there's good news on the horizon for Novavax, everyone's favorite scrappy, ...

At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Evidence shows that vaccines of shingles, even influenza and tuberculosis, can lower the incidence of the disease ...

Ivermectin (IVM) will now be sold over the counter (OTC) in at least one state, with other states in the process of granting ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

The Trump Administration’s sweeping FDA layoffs were supposed to spare ... delayed granting full approval to Novavax’s Covid-19 vaccine, which is currently under emergency use authorization.

The Centers for Disease Control and Prevention doctor in charge of monitoring reports of adverse COVID-19 vaccine reactions has been accused by a Republican senator of mishandling and possibly ...